nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Vismodegib—skin cancer	0.154	0.208	CbGbCtD
Riluzole—ABCG2—Vemurafenib—skin cancer	0.122	0.164	CbGbCtD
Riluzole—CYP1A2—Imiquimod—skin cancer	0.0915	0.123	CbGbCtD
Riluzole—CYP1A1—Dacarbazine—skin cancer	0.086	0.116	CbGbCtD
Riluzole—ABCG2—Dactinomycin—skin cancer	0.0808	0.109	CbGbCtD
Riluzole—ABCG2—Fluorouracil—skin cancer	0.0546	0.0737	CbGbCtD
Riluzole—CYP1A2—Vemurafenib—skin cancer	0.0501	0.0677	CbGbCtD
Riluzole—ABCG2—Docetaxel—skin cancer	0.0417	0.0563	CbGbCtD
Riluzole—CYP1A2—Dacarbazine—skin cancer	0.0384	0.0519	CbGbCtD
Riluzole—CYP1A2—Fluorouracil—skin cancer	0.0225	0.0304	CbGbCtD
Riluzole—SLC7A11—forelimb zeugopod—skin cancer	0.021	0.633	CbGeAlD
Riluzole—CYP1A1—skin epidermis—skin cancer	0.00212	0.0639	CbGeAlD
Riluzole—SLC7A11—female reproductive system—skin cancer	0.00164	0.0495	CbGeAlD
Riluzole—SLC7A11—head—skin cancer	0.00137	0.0413	CbGeAlD
Riluzole—CYP1A2—nipple—skin cancer	0.00104	0.0313	CbGeAlD
Riluzole—CYP1A1—nipple—skin cancer	0.00103	0.0309	CbGeAlD
Riluzole—SCN5A—head—skin cancer	0.000825	0.0249	CbGeAlD
Riluzole—CYP1A1—epithelium—skin cancer	0.000691	0.0208	CbGeAlD
Riluzole—CYP1A1—skin of body—skin cancer	0.000657	0.0198	CbGeAlD
Riluzole—ABCG2—mammalian vulva—skin cancer	0.000631	0.019	CbGeAlD
Riluzole—CYP1A1—mammalian vulva—skin cancer	0.000599	0.0181	CbGeAlD
Riluzole—CYP1A1—female reproductive system—skin cancer	0.000513	0.0155	CbGeAlD
Riluzole—CYP1A1—head—skin cancer	0.000429	0.0129	CbGeAlD
Riluzole—ABCG2—lymph node—skin cancer	0.000316	0.00953	CbGeAlD
Riluzole—CYP1A1—lymph node—skin cancer	0.0003	0.00905	CbGeAlD
Riluzole—Myalgia—Bleomycin—skin cancer	0.00019	0.000838	CcSEcCtD
Riluzole—Chest pain—Bleomycin—skin cancer	0.00019	0.000838	CcSEcCtD
Riluzole—Orthostatic hypotension—Docetaxel—skin cancer	0.000189	0.000838	CcSEcCtD
Riluzole—Rash—Vemurafenib—skin cancer	0.000189	0.000836	CcSEcCtD
Riluzole—Mental disorder—Temozolomide—skin cancer	0.000189	0.000836	CcSEcCtD
Riluzole—Dermatitis—Vemurafenib—skin cancer	0.000189	0.000835	CcSEcCtD
Riluzole—Hypersensitivity—Imiquimod—skin cancer	0.000188	0.000833	CcSEcCtD
Riluzole—Headache—Vemurafenib—skin cancer	0.000188	0.000831	CcSEcCtD
Riluzole—Malnutrition—Temozolomide—skin cancer	0.000188	0.00083	CcSEcCtD
Riluzole—Breast disorder—Docetaxel—skin cancer	0.000187	0.000829	CcSEcCtD
Riluzole—Discomfort—Bleomycin—skin cancer	0.000187	0.000828	CcSEcCtD
Riluzole—Malaise—Dactinomycin—skin cancer	0.000187	0.000828	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000187	0.000826	CcSEcCtD
Riluzole—Leukopenia—Dactinomycin—skin cancer	0.000186	0.000822	CcSEcCtD
Riluzole—Dysgeusia—Temozolomide—skin cancer	0.000184	0.000813	CcSEcCtD
Riluzole—Asthenia—Imiquimod—skin cancer	0.000184	0.000811	CcSEcCtD
Riluzole—Confusional state—Bleomycin—skin cancer	0.000183	0.00081	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000183	0.000809	CcSEcCtD
Riluzole—Anaphylactic shock—Bleomycin—skin cancer	0.000182	0.000803	CcSEcCtD
Riluzole—Oedema—Bleomycin—skin cancer	0.000182	0.000803	CcSEcCtD
Riluzole—Back pain—Temozolomide—skin cancer	0.000182	0.000803	CcSEcCtD
Riluzole—Pruritus—Imiquimod—skin cancer	0.000181	0.0008	CcSEcCtD
Riluzole—Infection—Bleomycin—skin cancer	0.000181	0.000798	CcSEcCtD
Riluzole—Dysphagia—Docetaxel—skin cancer	0.000179	0.000793	CcSEcCtD
Riluzole—Nausea—Vemurafenib—skin cancer	0.000178	0.000788	CcSEcCtD
Riluzole—Thrombocytopenia—Bleomycin—skin cancer	0.000178	0.000787	CcSEcCtD
Riluzole—Arrhythmia—Fluorouracil—skin cancer	0.000178	0.000785	CcSEcCtD
Riluzole—Myalgia—Dactinomycin—skin cancer	0.000177	0.000782	CcSEcCtD
Riluzole—Tremor—Temozolomide—skin cancer	0.000176	0.000778	CcSEcCtD
Riluzole—Alopecia—Fluorouracil—skin cancer	0.000176	0.000777	CcSEcCtD
Riluzole—Diarrhoea—Imiquimod—skin cancer	0.000175	0.000774	CcSEcCtD
Riluzole—Discomfort—Dactinomycin—skin cancer	0.000175	0.000772	CcSEcCtD
Riluzole—Angina pectoris—Docetaxel—skin cancer	0.000175	0.000772	CcSEcCtD
Riluzole—Ill-defined disorder—Temozolomide—skin cancer	0.000174	0.000771	CcSEcCtD
Riluzole—Anaemia—Temozolomide—skin cancer	0.000174	0.000768	CcSEcCtD
Riluzole—Anorexia—Bleomycin—skin cancer	0.000173	0.000766	CcSEcCtD
Riluzole—Agitation—Temozolomide—skin cancer	0.000173	0.000763	CcSEcCtD
Riluzole—Angioedema—Temozolomide—skin cancer	0.000172	0.000759	CcSEcCtD
Riluzole—Pancytopenia—Docetaxel—skin cancer	0.00017	0.000753	CcSEcCtD
Riluzole—Hypotension—Bleomycin—skin cancer	0.00017	0.000751	CcSEcCtD
Riluzole—Oedema—Dactinomycin—skin cancer	0.000169	0.000749	CcSEcCtD
Riluzole—Malaise—Temozolomide—skin cancer	0.000169	0.000749	CcSEcCtD
Riluzole—Dizziness—Imiquimod—skin cancer	0.000169	0.000748	CcSEcCtD
Riluzole—Vertigo—Temozolomide—skin cancer	0.000169	0.000746	CcSEcCtD
Riluzole—Infection—Dactinomycin—skin cancer	0.000168	0.000744	CcSEcCtD
Riluzole—Leukopenia—Temozolomide—skin cancer	0.000168	0.000743	CcSEcCtD
Riluzole—Neutropenia—Docetaxel—skin cancer	0.000168	0.000741	CcSEcCtD
Riluzole—Palpitations—Temozolomide—skin cancer	0.000166	0.000734	CcSEcCtD
Riluzole—Thrombocytopenia—Dactinomycin—skin cancer	0.000166	0.000734	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000166	0.000732	CcSEcCtD
Riluzole—Cough—Temozolomide—skin cancer	0.000164	0.000725	CcSEcCtD
Riluzole—Paraesthesia—Bleomycin—skin cancer	0.000163	0.000721	CcSEcCtD
Riluzole—Weight increased—Docetaxel—skin cancer	0.000163	0.000721	CcSEcCtD
Riluzole—Convulsion—Temozolomide—skin cancer	0.000163	0.00072	CcSEcCtD
Riluzole—Vomiting—Imiquimod—skin cancer	0.000163	0.000719	CcSEcCtD
Riluzole—Weight decreased—Docetaxel—skin cancer	0.000162	0.000717	CcSEcCtD
Riluzole—Hypertension—Temozolomide—skin cancer	0.000162	0.000717	CcSEcCtD
Riluzole—Dyspnoea—Bleomycin—skin cancer	0.000162	0.000716	CcSEcCtD
Riluzole—Anorexia—Dactinomycin—skin cancer	0.000162	0.000714	CcSEcCtD
Riluzole—Rash—Imiquimod—skin cancer	0.000161	0.000713	CcSEcCtD
Riluzole—Dermatitis—Imiquimod—skin cancer	0.000161	0.000712	CcSEcCtD
Riluzole—Pneumonia—Docetaxel—skin cancer	0.000161	0.000711	CcSEcCtD
Riluzole—Headache—Imiquimod—skin cancer	0.00016	0.000709	CcSEcCtD
Riluzole—Anaemia—Fluorouracil—skin cancer	0.00016	0.000707	CcSEcCtD
Riluzole—Arthralgia—Temozolomide—skin cancer	0.00016	0.000707	CcSEcCtD
Riluzole—Myalgia—Temozolomide—skin cancer	0.00016	0.000707	CcSEcCtD
Riluzole—Infestation NOS—Docetaxel—skin cancer	0.00016	0.000707	CcSEcCtD
Riluzole—Infestation—Docetaxel—skin cancer	0.00016	0.000707	CcSEcCtD
Riluzole—Anxiety—Temozolomide—skin cancer	0.000159	0.000705	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000159	0.000702	CcSEcCtD
Riluzole—Discomfort—Temozolomide—skin cancer	0.000158	0.000699	CcSEcCtD
Riluzole—Decreased appetite—Bleomycin—skin cancer	0.000158	0.000698	CcSEcCtD
Riluzole—Acute coronary syndrome—Docetaxel—skin cancer	0.000158	0.000697	CcSEcCtD
Riluzole—Myocardial infarction—Docetaxel—skin cancer	0.000157	0.000693	CcSEcCtD
Riluzole—Neuropathy peripheral—Docetaxel—skin cancer	0.000157	0.000693	CcSEcCtD
Riluzole—Dry mouth—Temozolomide—skin cancer	0.000156	0.000691	CcSEcCtD
Riluzole—Stomatitis—Docetaxel—skin cancer	0.000156	0.000689	CcSEcCtD
Riluzole—Jaundice—Docetaxel—skin cancer	0.000156	0.000689	CcSEcCtD
Riluzole—Pain—Bleomycin—skin cancer	0.000155	0.000687	CcSEcCtD
Riluzole—Leukopenia—Fluorouracil—skin cancer	0.000155	0.000685	CcSEcCtD
Riluzole—Confusional state—Temozolomide—skin cancer	0.000155	0.000683	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000154	0.000683	CcSEcCtD
Riluzole—Anaphylactic shock—Temozolomide—skin cancer	0.000153	0.000678	CcSEcCtD
Riluzole—Oedema—Temozolomide—skin cancer	0.000153	0.000678	CcSEcCtD
Riluzole—Infection—Temozolomide—skin cancer	0.000152	0.000673	CcSEcCtD
Riluzole—Nausea—Imiquimod—skin cancer	0.000152	0.000672	CcSEcCtD
Riluzole—Hepatobiliary disease—Docetaxel—skin cancer	0.000151	0.000668	CcSEcCtD
Riluzole—Epistaxis—Docetaxel—skin cancer	0.000151	0.000667	CcSEcCtD
Riluzole—Nervous system disorder—Temozolomide—skin cancer	0.00015	0.000665	CcSEcCtD
Riluzole—Thrombocytopenia—Temozolomide—skin cancer	0.00015	0.000664	CcSEcCtD
Riluzole—Convulsion—Fluorouracil—skin cancer	0.00015	0.000663	CcSEcCtD
Riluzole—Feeling abnormal—Bleomycin—skin cancer	0.00015	0.000662	CcSEcCtD
Riluzole—Agranulocytosis—Docetaxel—skin cancer	0.000149	0.000659	CcSEcCtD
Riluzole—Skin disorder—Temozolomide—skin cancer	0.000149	0.000658	CcSEcCtD
Riluzole—Hyperhidrosis—Temozolomide—skin cancer	0.000148	0.000655	CcSEcCtD
Riluzole—Myalgia—Fluorouracil—skin cancer	0.000147	0.000651	CcSEcCtD
Riluzole—Chest pain—Fluorouracil—skin cancer	0.000147	0.000651	CcSEcCtD
Riluzole—Decreased appetite—Dactinomycin—skin cancer	0.000147	0.000651	CcSEcCtD
Riluzole—Fatigue—Dactinomycin—skin cancer	0.000146	0.000646	CcSEcCtD
Riluzole—Anorexia—Temozolomide—skin cancer	0.000146	0.000646	CcSEcCtD
Riluzole—Discomfort—Fluorouracil—skin cancer	0.000146	0.000644	CcSEcCtD
Riluzole—Pain—Dactinomycin—skin cancer	0.000145	0.000641	CcSEcCtD
Riluzole—Urticaria—Bleomycin—skin cancer	0.000144	0.000638	CcSEcCtD
Riluzole—Haemoglobin—Docetaxel—skin cancer	0.000144	0.000638	CcSEcCtD
Riluzole—Rhinitis—Docetaxel—skin cancer	0.000144	0.000636	CcSEcCtD
Riluzole—Body temperature increased—Bleomycin—skin cancer	0.000144	0.000635	CcSEcCtD
Riluzole—Haemorrhage—Docetaxel—skin cancer	0.000143	0.000634	CcSEcCtD
Riluzole—Hepatitis—Docetaxel—skin cancer	0.000143	0.000634	CcSEcCtD
Riluzole—Hypoaesthesia—Docetaxel—skin cancer	0.000143	0.000631	CcSEcCtD
Riluzole—Confusional state—Fluorouracil—skin cancer	0.000142	0.00063	CcSEcCtD
Riluzole—Pharyngitis—Docetaxel—skin cancer	0.000142	0.00063	CcSEcCtD
Riluzole—Urinary tract disorder—Docetaxel—skin cancer	0.000142	0.000627	CcSEcCtD
Riluzole—Oedema peripheral—Docetaxel—skin cancer	0.000141	0.000625	CcSEcCtD
Riluzole—Oedema—Fluorouracil—skin cancer	0.000141	0.000624	CcSEcCtD
Riluzole—Anaphylactic shock—Fluorouracil—skin cancer	0.000141	0.000624	CcSEcCtD
Riluzole—Connective tissue disorder—Docetaxel—skin cancer	0.000141	0.000623	CcSEcCtD
Riluzole—Urethral disorder—Docetaxel—skin cancer	0.000141	0.000622	CcSEcCtD
Riluzole—Infection—Fluorouracil—skin cancer	0.00014	0.00062	CcSEcCtD
Riluzole—Feeling abnormal—Dactinomycin—skin cancer	0.00014	0.000618	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00014	0.000617	CcSEcCtD
Riluzole—Insomnia—Temozolomide—skin cancer	0.000139	0.000613	CcSEcCtD
Riluzole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000139	0.000613	CcSEcCtD
Riluzole—Nervous system disorder—Fluorouracil—skin cancer	0.000139	0.000612	CcSEcCtD
Riluzole—Thrombocytopenia—Fluorouracil—skin cancer	0.000138	0.000611	CcSEcCtD
Riluzole—Tachycardia—Fluorouracil—skin cancer	0.000138	0.000609	CcSEcCtD
Riluzole—Paraesthesia—Temozolomide—skin cancer	0.000138	0.000609	CcSEcCtD
Riluzole—Dyspnoea—Temozolomide—skin cancer	0.000137	0.000604	CcSEcCtD
Riluzole—Somnolence—Temozolomide—skin cancer	0.000136	0.000603	CcSEcCtD
Riluzole—Erythema multiforme—Docetaxel—skin cancer	0.000136	0.0006	CcSEcCtD
Riluzole—Dyspepsia—Temozolomide—skin cancer	0.000135	0.000597	CcSEcCtD
Riluzole—Anorexia—Fluorouracil—skin cancer	0.000135	0.000595	CcSEcCtD
Riluzole—Eye disorder—Docetaxel—skin cancer	0.000134	0.000593	CcSEcCtD
Riluzole—Abdominal pain—Dactinomycin—skin cancer	0.000134	0.000592	CcSEcCtD
Riluzole—Body temperature increased—Dactinomycin—skin cancer	0.000134	0.000592	CcSEcCtD
Riluzole—Hypersensitivity—Bleomycin—skin cancer	0.000134	0.000592	CcSEcCtD
Riluzole—Decreased appetite—Temozolomide—skin cancer	0.000133	0.000589	CcSEcCtD
Riluzole—Cardiac disorder—Docetaxel—skin cancer	0.000133	0.000589	CcSEcCtD
Riluzole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000132	0.000585	CcSEcCtD
Riluzole—Fatigue—Temozolomide—skin cancer	0.000132	0.000584	CcSEcCtD
Riluzole—Hypotension—Fluorouracil—skin cancer	0.000132	0.000584	CcSEcCtD
Riluzole—Pain—Temozolomide—skin cancer	0.000131	0.00058	CcSEcCtD
Riluzole—Constipation—Temozolomide—skin cancer	0.000131	0.00058	CcSEcCtD
Riluzole—Asthenia—Bleomycin—skin cancer	0.00013	0.000576	CcSEcCtD
Riluzole—Angiopathy—Docetaxel—skin cancer	0.00013	0.000576	CcSEcCtD
Riluzole—Immune system disorder—Docetaxel—skin cancer	0.00013	0.000573	CcSEcCtD
Riluzole—Mediastinal disorder—Docetaxel—skin cancer	0.000129	0.000572	CcSEcCtD
Riluzole—Chills—Docetaxel—skin cancer	0.000129	0.000569	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000129	0.000569	CcSEcCtD
Riluzole—Pruritus—Bleomycin—skin cancer	0.000129	0.000568	CcSEcCtD
Riluzole—Arrhythmia—Docetaxel—skin cancer	0.000128	0.000567	CcSEcCtD
Riluzole—Insomnia—Fluorouracil—skin cancer	0.000128	0.000565	CcSEcCtD
Riluzole—Paraesthesia—Fluorouracil—skin cancer	0.000127	0.000561	CcSEcCtD
Riluzole—Alopecia—Docetaxel—skin cancer	0.000127	0.000561	CcSEcCtD
Riluzole—Feeling abnormal—Temozolomide—skin cancer	0.000126	0.000559	CcSEcCtD
Riluzole—Dyspnoea—Fluorouracil—skin cancer	0.000126	0.000557	CcSEcCtD
Riluzole—Mental disorder—Docetaxel—skin cancer	0.000126	0.000556	CcSEcCtD
Riluzole—Somnolence—Fluorouracil—skin cancer	0.000126	0.000555	CcSEcCtD
Riluzole—Gastrointestinal pain—Temozolomide—skin cancer	0.000125	0.000554	CcSEcCtD
Riluzole—Malnutrition—Docetaxel—skin cancer	0.000125	0.000552	CcSEcCtD
Riluzole—Hypersensitivity—Dactinomycin—skin cancer	0.000125	0.000552	CcSEcCtD
Riluzole—Dyspepsia—Fluorouracil—skin cancer	0.000124	0.00055	CcSEcCtD
Riluzole—Decreased appetite—Fluorouracil—skin cancer	0.000123	0.000543	CcSEcCtD
Riluzole—Dysgeusia—Docetaxel—skin cancer	0.000122	0.000541	CcSEcCtD
Riluzole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000122	0.000539	CcSEcCtD
Riluzole—Urticaria—Temozolomide—skin cancer	0.000122	0.000538	CcSEcCtD
Riluzole—Asthenia—Dactinomycin—skin cancer	0.000122	0.000538	CcSEcCtD
Riluzole—Abdominal pain—Temozolomide—skin cancer	0.000121	0.000536	CcSEcCtD
Riluzole—Body temperature increased—Temozolomide—skin cancer	0.000121	0.000536	CcSEcCtD
Riluzole—Back pain—Docetaxel—skin cancer	0.000121	0.000534	CcSEcCtD
Riluzole—Pain—Fluorouracil—skin cancer	0.000121	0.000534	CcSEcCtD
Riluzole—Muscle spasms—Docetaxel—skin cancer	0.00012	0.000531	CcSEcCtD
Riluzole—Feeling abnormal—Fluorouracil—skin cancer	0.000116	0.000515	CcSEcCtD
Riluzole—Diarrhoea—Dactinomycin—skin cancer	0.000116	0.000513	CcSEcCtD
Riluzole—Vomiting—Bleomycin—skin cancer	0.000116	0.000511	CcSEcCtD
Riluzole—Anaemia—Docetaxel—skin cancer	0.000115	0.00051	CcSEcCtD
Riluzole—Rash—Bleomycin—skin cancer	0.000115	0.000507	CcSEcCtD
Riluzole—Dermatitis—Bleomycin—skin cancer	0.000114	0.000506	CcSEcCtD
Riluzole—Hypersensitivity—Temozolomide—skin cancer	0.000113	0.000499	CcSEcCtD
Riluzole—Urticaria—Fluorouracil—skin cancer	0.000112	0.000496	CcSEcCtD
Riluzole—Syncope—Docetaxel—skin cancer	0.000112	0.000495	CcSEcCtD
Riluzole—Leukopenia—Docetaxel—skin cancer	0.000112	0.000494	CcSEcCtD
Riluzole—Body temperature increased—Fluorouracil—skin cancer	0.000112	0.000494	CcSEcCtD
Riluzole—Palpitations—Docetaxel—skin cancer	0.00011	0.000488	CcSEcCtD
Riluzole—Asthenia—Temozolomide—skin cancer	0.00011	0.000486	CcSEcCtD
Riluzole—Loss of consciousness—Docetaxel—skin cancer	0.00011	0.000485	CcSEcCtD
Riluzole—Cough—Docetaxel—skin cancer	0.000109	0.000482	CcSEcCtD
Riluzole—Pruritus—Temozolomide—skin cancer	0.000108	0.00048	CcSEcCtD
Riluzole—Convulsion—Docetaxel—skin cancer	0.000108	0.000478	CcSEcCtD
Riluzole—Nausea—Bleomycin—skin cancer	0.000108	0.000477	CcSEcCtD
Riluzole—Hypertension—Docetaxel—skin cancer	0.000108	0.000477	CcSEcCtD
Riluzole—Vomiting—Dactinomycin—skin cancer	0.000108	0.000476	CcSEcCtD
Riluzole—Rash—Dactinomycin—skin cancer	0.000107	0.000472	CcSEcCtD
Riluzole—Chest pain—Docetaxel—skin cancer	0.000106	0.00047	CcSEcCtD
Riluzole—Myalgia—Docetaxel—skin cancer	0.000106	0.00047	CcSEcCtD
Riluzole—Arthralgia—Docetaxel—skin cancer	0.000106	0.00047	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000106	0.000467	CcSEcCtD
Riluzole—Diarrhoea—Temozolomide—skin cancer	0.000105	0.000464	CcSEcCtD
Riluzole—Hypersensitivity—Fluorouracil—skin cancer	0.000104	0.00046	CcSEcCtD
Riluzole—Dry mouth—Docetaxel—skin cancer	0.000104	0.00046	CcSEcCtD
Riluzole—Confusional state—Docetaxel—skin cancer	0.000103	0.000454	CcSEcCtD
Riluzole—Anaphylactic shock—Docetaxel—skin cancer	0.000102	0.000451	CcSEcCtD
Riluzole—Oedema—Docetaxel—skin cancer	0.000102	0.000451	CcSEcCtD
Riluzole—Dizziness—Temozolomide—skin cancer	0.000101	0.000448	CcSEcCtD
Riluzole—Infection—Docetaxel—skin cancer	0.000101	0.000448	CcSEcCtD
Riluzole—Nausea—Dactinomycin—skin cancer	0.000101	0.000445	CcSEcCtD
Riluzole—Shock—Docetaxel—skin cancer	0.0001	0.000443	CcSEcCtD
Riluzole—Nervous system disorder—Docetaxel—skin cancer	0.0001	0.000442	CcSEcCtD
Riluzole—Pruritus—Fluorouracil—skin cancer	9.99e-05	0.000442	CcSEcCtD
Riluzole—Thrombocytopenia—Docetaxel—skin cancer	9.98e-05	0.000441	CcSEcCtD
Riluzole—Tachycardia—Docetaxel—skin cancer	9.95e-05	0.00044	CcSEcCtD
Riluzole—Skin disorder—Docetaxel—skin cancer	9.9e-05	0.000438	CcSEcCtD
Riluzole—Vomiting—Temozolomide—skin cancer	9.75e-05	0.000431	CcSEcCtD
Riluzole—Anorexia—Docetaxel—skin cancer	9.72e-05	0.00043	CcSEcCtD
Riluzole—Rash—Temozolomide—skin cancer	9.66e-05	0.000427	CcSEcCtD
Riluzole—Diarrhoea—Fluorouracil—skin cancer	9.66e-05	0.000427	CcSEcCtD
Riluzole—Dermatitis—Temozolomide—skin cancer	9.66e-05	0.000427	CcSEcCtD
Riluzole—Headache—Temozolomide—skin cancer	9.6e-05	0.000425	CcSEcCtD
Riluzole—Hypotension—Docetaxel—skin cancer	9.53e-05	0.000421	CcSEcCtD
Riluzole—Dizziness—Fluorouracil—skin cancer	9.34e-05	0.000413	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Docetaxel—skin cancer	9.29e-05	0.000411	CcSEcCtD
Riluzole—Insomnia—Docetaxel—skin cancer	9.22e-05	0.000408	CcSEcCtD
Riluzole—Paraesthesia—Docetaxel—skin cancer	9.15e-05	0.000405	CcSEcCtD
Riluzole—Nausea—Temozolomide—skin cancer	9.1e-05	0.000403	CcSEcCtD
Riluzole—Dyspnoea—Docetaxel—skin cancer	9.09e-05	0.000402	CcSEcCtD
Riluzole—Somnolence—Docetaxel—skin cancer	9.06e-05	0.000401	CcSEcCtD
Riluzole—Vomiting—Fluorouracil—skin cancer	8.98e-05	0.000397	CcSEcCtD
Riluzole—Dyspepsia—Docetaxel—skin cancer	8.97e-05	0.000397	CcSEcCtD
Riluzole—Rash—Fluorouracil—skin cancer	8.91e-05	0.000394	CcSEcCtD
Riluzole—Dermatitis—Fluorouracil—skin cancer	8.9e-05	0.000393	CcSEcCtD
Riluzole—Decreased appetite—Docetaxel—skin cancer	8.86e-05	0.000392	CcSEcCtD
Riluzole—Headache—Fluorouracil—skin cancer	8.85e-05	0.000391	CcSEcCtD
Riluzole—Gastrointestinal disorder—Docetaxel—skin cancer	8.8e-05	0.000389	CcSEcCtD
Riluzole—Fatigue—Docetaxel—skin cancer	8.79e-05	0.000389	CcSEcCtD
Riluzole—Constipation—Docetaxel—skin cancer	8.72e-05	0.000385	CcSEcCtD
Riluzole—Pain—Docetaxel—skin cancer	8.72e-05	0.000385	CcSEcCtD
Riluzole—Feeling abnormal—Docetaxel—skin cancer	8.4e-05	0.000371	CcSEcCtD
Riluzole—Nausea—Fluorouracil—skin cancer	8.39e-05	0.000371	CcSEcCtD
Riluzole—Gastrointestinal pain—Docetaxel—skin cancer	8.34e-05	0.000369	CcSEcCtD
Riluzole—Abdominal pain—Docetaxel—skin cancer	8.06e-05	0.000356	CcSEcCtD
Riluzole—Body temperature increased—Docetaxel—skin cancer	8.06e-05	0.000356	CcSEcCtD
Riluzole—Hypersensitivity—Docetaxel—skin cancer	7.51e-05	0.000332	CcSEcCtD
Riluzole—Asthenia—Docetaxel—skin cancer	7.31e-05	0.000323	CcSEcCtD
Riluzole—Pruritus—Docetaxel—skin cancer	7.21e-05	0.000319	CcSEcCtD
Riluzole—Diarrhoea—Docetaxel—skin cancer	6.97e-05	0.000308	CcSEcCtD
Riluzole—Dizziness—Docetaxel—skin cancer	6.74e-05	0.000298	CcSEcCtD
Riluzole—Vomiting—Docetaxel—skin cancer	6.48e-05	0.000287	CcSEcCtD
Riluzole—Rash—Docetaxel—skin cancer	6.43e-05	0.000284	CcSEcCtD
Riluzole—Dermatitis—Docetaxel—skin cancer	6.42e-05	0.000284	CcSEcCtD
Riluzole—Headache—Docetaxel—skin cancer	6.39e-05	0.000282	CcSEcCtD
Riluzole—Nausea—Docetaxel—skin cancer	6.05e-05	0.000268	CcSEcCtD
